What Is Melasma and Why Do These Brown Spots Form?

Melasma is a chronic dysregulation of melanin synthesis that produces irregular brown to gray-brown patches on sun-exposed skin, driven by the interaction of hormones, UV radiation, and genetic susceptibility across multiple skin depths. The disorder isn't a surface-level stain—it's a full-thickness breakdown in melanocyte control logic. Understanding this architecture explains the high recurrence rates and the frustration with superficial removal attempts.

Why Melasma Is Not a Surface-Exclusive Phenomenon

Melasma originates from melanocytes in the basal epidermis, but its pathology extends deeper. In normal skin, melanin production follows a stimulus-response loop: UV damage signals keratinocytes to release melanogenic factors, melanocytes respond with melanosome transfer to shield nuclei, and the process winds down once the stimulus ceases. Melasma breaks this loop. Estrogen and progesterone lower the activation threshold, UV and visible light drive continuous signaling, and the genetic wiring determines the gain on the system. The melanocytes not only overproduce melanin but often eject it into the dermis, where it is consumed by melanophages and persists as blue-gray pigmentation. A Wood’s lamp can separate epidermal (enhanced) from dermal (not enhanced) involvement, but true melasma frequently presents a mixed pattern. The dermal component traps pigment in a layer that lacks the epidermal shedding mechanism, making it far more stable.

The problem isn't just melanocytic. Fibroblasts and dermal blood vessels secrete growth factors and cytokines that reinforce the melanogenic drive, creating a self-sustaining network. Even perilesional skin—apparently normal—shows elevated melanocyte activity under microscopy, which is why patches expand gradually and fail to clear evenly. The whole affected field is dysfunctional, not just the visible areas.

The Three-Trigger System That Locks Melasma In

Hormones as a Threshold Reducer

Estrogen and progesterone bind to melanocyte receptors, upregulating tyrosinase and increasing melanosome production. This is the known link to pregnancy, oral contraceptives, and hormone therapy, but the long-term consequence is more consequential: the melanocyte becomes permanently sensitized. After a hormone-driven episode, even trivial UV doses can reignite the process. Fitzpatrick types III-V, with their inherently active melanocytes, experience a more pronounced sensitization, often leading to deeper pigment involvement and a larger surface area.

Light as a Non-Stop Accelerant

UVA, UVB, and blue visible light all stimulate melanogenesis, with penetration varying by wavelength. UVB mostly acts superficially; UVA and high-energy visible light reach the dermis, fueling both superficial and deep pigmentation. The mechanism includes direct melanocyte activation, oxidative stress, and a paracrine storm from keratinocytes and fibroblasts that churn out endothelin-1 and stem cell factor. Chronic low-dose exposure—commuting, working near windows—maintains the feedback loop. The seasonal pattern (summer darkening, winter fading, spring relapse) mirrors the accumulation and partial degradation of this light-driven output.

Genetics as the System’s Baseline Gain

A positive family history is one of the strongest predictors, and twin concordance points to significant heritability. Polymorphisms in melanocortin 1 receptor pathways set the default reactivity of melanocytes. Fitzpatrick phototypes III-V sit at the intersection: enough melanin to protect against acute burning but not enough to fully block the deep-penetrating wavelengths that activate dermal pathways. In type V, dermal melasma is particularly common, contributing to treatment resistance. Lighter types (I-II) rarely develop melasma unless under extreme hormonal provocation, and in very dark type VI skin, the high basal melanin may mask the onset, though the condition occurs.

The Self-Reinforcing Cycle

These three triggers don't simply add up—they multiply each other’s effects. Hormonal priming reduces the UV dose needed to kick off a response; genetics sets the magnitude. Once the cycle is established, UV stimulates pigment, pigment absorbs more radiation, increasing local oxidative stress, which further activates melanocytes. The result is a positive-feedback architecture. Even removing one trigger (e.g., discontinuing an oral contraceptive) often fails to fully shut the system down because the melanocytes retain their hyper-reactive state. This “memory” is the physiological basis for recurrence; it’s not a failure of adherence but a property of the reprogrammed cellular network.

When Melasma Warrants Medical Attention vs. When It Stays Cosmetic

When to Investigate Further

Melasma is benign, but a sudden or diffuse hyperpigmentation can mimic the skin changes of adrenal insufficiency (Addison’s disease) or thyroid hormone imbalance. If facial pigmentation is accompanied by fatigue, weight shifts, or mucosal darkening, lab investigation is reasonable. A new, asymmetric, or solitary pigmented lesion in the melasma-prone facial area should never be assumed to be melasma; dermoscopy is mandatory to exclude melanoma, especially in skin of color where acral lentiginous melanoma can present outside the typical extremities. Melasma itself has no malignant potential, but its presence shouldn’t delay a biopsy if a concerning lesion exists.

When It Remains a Purely Cosmetic Issue

In the large majority, melasma emerges predictably from hormonal events, UV exposure, and genetic predisposition in an otherwise healthy body. It does not signal internal disease, organ failure, or systemic illness. Pregnancy-related melasma often dims postpartum; pill-related melasma may stabilize. Lab values are normal. At that point, the condition should be classified as a local dysregulation of melanin production, not a red flag for hidden pathology. This distinction prevents unnecessary anxiety and directs the focus toward understanding triggers and the natural history.

Conceptual Tools That Explain Melasma Behavior

• Epidermal vs. Dermal Pigment Deposition: Defines visible color and management difficulty; epidermal pigment is brown and accessible, dermal pigment is blue-gray and requires endogenous clearance systems.
• Fitzpatrick Phototype: Encodes baseline melanocyte reactivity; types III-V represent the high-risk window due to melanocytes poised for robust UV response.
• Melanocyte Stability: A measure of whether a cell returns to baseline; melasma involves a persistent hyperactivated state, not a temporary surge.
• Post-Inflammatory Hyperpigmentation (PIH): Mechanistically downstream of the same melanogenesis pathways but initiated by injury, not the melasma-specific triad. Differentiating between the two is necessary for trigger-based strategies.

Questions That Follow the Understanding of Melasma’s Logic

Can melasma resolve without intervention?

It can wane when the primary hormonal trigger is removed—postpartum or after stopping an estrogen-containing contraceptive—but the underlying threshold remains lowered. Full spontaneous resolution without recurrence is rare unless strict light avoidance is maintained indefinitely.

Is melasma a permanent feature?

Permanence implies constant visibility; melasma is chronic with fluctuations. Deep dermal components may never fully clear, while superficial components can fade seasonally. The condition should be expected to recur in the absence of long-term trigger control.

Does melasma occur only in women?

No. Women account for roughly 90% of cases due to reproductive hormone dynamics, but men develop melasma, often linked to occupational UV exposure and a background genetic susceptibility. The cellular mechanism is identical.

Is sun exposure the sole cause?

No. UV is the most potent perpetuator but not the initiator; without hormonal or genetic priming, equivalent sun exposure produces a simple tan. Melasma is a multifactorial condition that requires at least two of the three triggers to manifest.

Why do patches grow larger over time?

The field defect extends beyond visible borders; subclinically activated melanocytes gradually reach the threshold for visible pigmentation with continued stimulation. So apparent “spread” is actually the progressive unmasking of a pre-existing, broader instability.

The Next Logical Question After the ‘Why’

Once melasma is understood as a systems failure of melanin regulation rather than a superficial discoloration, the follow-up is diagnostic: Is my brown spot melasma or another entity? The answer determines whether the focus should be on trigger management, camouflage, or a different approach entirely. A comparative guide that maps lesion characteristics and patterns to specific hyperpigmentations—solar lentigo, PIH, melasma—provides that essential first step.